SP
Swisscanto Private Equity
Swisscanto Private Equity is a Series C stage investment firm. It has made 5 investments.
Portfolio
5
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Team
RS
Robert Schier
Investment Director
AN
Andreas Nicoli
Head
SV
Sebastien Valdemar Marang
Private Equity
Portfolio Breakdown
Stage Distribution
Investment Activity
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| MMemo Therapeutics AG | Series C | — | May 2024 |
| NNIL Technology | Unknown | — | May 2024 |
| MMemo Therapeutics AG | Series C | — | Nov 2023 |
| MMedimaps Group | Unknown | $20M | Jan 2021 |
| Unknown | — | — | |
| Unknown | $20M | — |
Top Co-Investors
Verve Ventures5 shared
Schroders Capital2 shared
Vesalius Biocapital2 shared
Pureos Bioventures2 shared
Idinvest Partners2 shared
Swisscom Ventures2 shared
imec.xpand1 shared
Excellis1 shared
Zürcher Kantonalbank1 shared
Ysios Capital1 shared
Kurma Partners1 shared
Credit Suisse Group AG1 shared
Jolt Capital1 shared
NGP Capital1 shared
EIFO1 shared
Last updated: 8 September 2026